PMID- 29982264 OWN - NLM STAT- MEDLINE DCOM- 20181024 LR - 20181114 IS - 1643-3750 (Electronic) IS - 1234-1010 (Print) IS - 1234-1010 (Linking) VI - 24 DP - 2018 Jul 8 TI - Involvement of T-Helper 9 Activation in a Mouse Model of Allergic Rhinitis. PG - 4704-4710 LID - 10.12659/MSM.908302 [doi] AB - BACKGROUND We aimed to investigate the role of T-Helper (TH) 9 cells in the pathogenesis of allergic rhinitis (AR) in mice. MATERIAL AND METHODS An AR model was produced in BALB/c mice, and the viral encoding interleukin (IL)-9 silencing sequence was used to reduce IL-9 expression. The experiment was divided into a control group, an AR group, an IL-9 shRNA+AR group, and a vector+AR group. Hematoxylin and eosin (H&E) staining was used to detect pathological changes. The cytokine expression was detected by ELISA method. Cellular typing was detected by flow cytometry. RESULTS Cells in the control group were regularly arranged, with clear layers and no congestion, edema, or necrosis observable. By contrast, in the AR model group and the vector treatment group, nasal mucosa showed clear hyperemia and edema in upper tissues and infiltration of inflammatory cells, which were ameliorated by IL-9 silencing. Compared with the control group, interferon-gamma (IFN-gamma) was significantly down-regulated, while IL-4, IL-17, and IL-9 were significantly elevated in the AR model group. TH1 cells in nasal mucosa, lymph, nasal lavage, spleen, and peripheral blood were significantly reduced, while TH2, TH9, TH17, and Treg cells were significantly elevated in the AR group compared with the control group. Importantly, all these changes in AR model were ameliorated by IL-9 silencing. CONCLUSIONS AR is related to the changes of cytokines in TH1, TH2, TH9, TH17, and Treg, which are improved by IL-9 silencing. Activation of TH9 cells is involved in the pathogenesis of AR. FAU - Jiang, Xunshuo AU - Jiang X AD - Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China (mainland). FAU - Zhang, Xiaona AU - Zhang X AD - Department of Otorhinolaryngology Head and Neck Surgery, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China (mainland). FAU - Liu, Jianguo AU - Liu J AD - Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China (mainland). FAU - Liu, Jiali AU - Liu J AD - Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China (mainland). FAU - Zhu, Xinhua AU - Zhu X AD - Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China (mainland). FAU - Yang, Chunping AU - Yang C AD - Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China (mainland). AD - Department of Otorhinolaryngology Head and Neck Surgery, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China (mainland). LA - eng PT - Journal Article DEP - 20180708 PL - United States TA - Med Sci Monit JT - Medical science monitor : international medical journal of experimental and clinical research JID - 9609063 RN - 0 (Cytokines) RN - 0 (Interleukin-17) RN - 0 (Interleukin-9) RN - 207137-56-2 (Interleukin-4) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Animals MH - Cytokines/immunology MH - Disease Models, Animal MH - Interferon-gamma MH - Interleukin-17/immunology/metabolism MH - Interleukin-4/immunology/metabolism MH - Interleukin-9/antagonists & inhibitors/*immunology/metabolism MH - Male MH - Mice MH - Mice, Inbred BALB C MH - Nasal Mucosa/immunology MH - Rhinitis, Allergic/*immunology/pathology MH - T-Lymphocytes, Helper-Inducer/*immunology/metabolism MH - T-Lymphocytes, Regulatory/immunology/metabolism MH - Th1 Cells/immunology/metabolism MH - Th2 Cells/immunology/metabolism PMC - PMC6069443 EDAT- 2018/07/10 06:00 MHDA- 2018/10/26 06:00 PMCR- 2018/07/08 CRDT- 2018/07/09 06:00 PHST- 2018/07/09 06:00 [entrez] PHST- 2018/07/10 06:00 [pubmed] PHST- 2018/10/26 06:00 [medline] PHST- 2018/07/08 00:00 [pmc-release] AID - 908302 [pii] AID - 10.12659/MSM.908302 [doi] PST - epublish SO - Med Sci Monit. 2018 Jul 8;24:4704-4710. doi: 10.12659/MSM.908302.